163 related articles for article (PubMed ID: 6260514)
1. Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers.
Hedler L; Stamm G; Weitzell R; Starke K
Eur J Pharmacol; 1981 Mar; 70(1):43-52. PubMed ID: 6260514
[TBL] [Abstract][Full Text] [Related]
2. alpha-Adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of the biophase concentration of noradrenaline.
Reichenbacher D; Reimann W; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):71-7. PubMed ID: 6125897
[TBL] [Abstract][Full Text] [Related]
3. Release of [3H]-amezinium from cortical noradrenergic axons: a model for the study of the alpha-autoreceptor hypothesis.
Hedler L; Starke K; Steppeler A
Br J Pharmacol; 1983 Apr; 78(4):645-53. PubMed ID: 6303483
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by yohimbine of the calcium-dependent evoked release of [3H]GABA in rat and mouse brain slices in vitro.
Maurin Y; Arbilla S; Langer SZ
Eur J Pharmacol; 1985 Apr; 111(1):37-48. PubMed ID: 2990943
[TBL] [Abstract][Full Text] [Related]
5. Mutual interaction of histamine H3-receptors and alpha 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex.
Schlicker E; Behling A; Lümmen G; Malinowska B; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):639-46. PubMed ID: 1353253
[TBL] [Abstract][Full Text] [Related]
6. Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Scheibner J; Trendelenburg AU; Hein L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Oct; 364(4):321-8. PubMed ID: 11683519
[TBL] [Abstract][Full Text] [Related]
7. Effects of 4-chloro-2-(2-imidazolin-2-ylamino)-isoindoline Hydrochloride (BE 6143) at pre- and postsynaptic alpha-adrenoceptors in rabbit aorta and pulmonary artery.
Docherty JR; Göthert M; Dieckhöfer C; Starke K
Arzneimittelforschung; 1982; 32(12):1534-40. PubMed ID: 6297514
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
Jackisch R; Moll S; Feuerstein TJ; Hertting G
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):105-13. PubMed ID: 2995843
[TBL] [Abstract][Full Text] [Related]
9. Pre- and postsynaptic alpha adrenoceptor selectivity studies with yohimbine and its two diastereoisomers rauwolscine and corynanthine in the anesthetized dog.
Shepperson NB; Duval N; Massingham R; Langer SZ
J Pharmacol Exp Ther; 1981 Nov; 219(2):540-6. PubMed ID: 6270312
[TBL] [Abstract][Full Text] [Related]
10. Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists.
Feuerstein TJ; Hertting G; Jackisch R
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):216-21. PubMed ID: 2991775
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a physiological role of presynaptic alpha-adrenoceptors: modulation of noradrenaline release in the pithed rabbit.
Majewski H; Hedler L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):256-63. PubMed ID: 6141531
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
Doxey JC; Lane AC; Roach AG; Virdee NK
Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic alpha-adrenoceptors: do exogenous and neuronally released noradrenaline act at different sites?
Baker DJ; Drew GM; Hilditch A
Br J Pharmacol; 1984 Mar; 81(3):457-64. PubMed ID: 6320940
[TBL] [Abstract][Full Text] [Related]
14. Protection of presynaptic alpha-adrenoceptors against irreversible blockade by phenoxybenzamine: preservation of the modulatory effects of exogenous noradrenaline and yohimbine.
Limberger N; Hölting T; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):155-60. PubMed ID: 2825039
[TBL] [Abstract][Full Text] [Related]
15. Modulation of noradrenaline release in human saphenous vein via presynaptic alpha 2-adrenoceptors.
Göthert M; Schlicker E; Hentrich F; Rohm N; Zerkowski HR
Eur J Pharmacol; 1984 Jul; 102(2):261-7. PubMed ID: 6148249
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.
Limberger N; Späth L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):53-61. PubMed ID: 2907100
[TBL] [Abstract][Full Text] [Related]
17. Alpha-adrenoceptor antagonists and the release of noradrenaline in rabbit cerebral cortex slices: support for the alpha-autoreceptor hypothesis.
Heepe P; Starke K
Br J Pharmacol; 1985 Jan; 84(1):147-55. PubMed ID: 2858231
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic alpha 2-adrenoceptor antagonism by verapamil but not by diltiazem in rabbit hypothalamic slices.
Galzin AM; Langer SZ
Br J Pharmacol; 1983 Mar; 78(3):571-7. PubMed ID: 6132643
[TBL] [Abstract][Full Text] [Related]
19. Further study of prerequisites for the enhancement by alpha-adrenoceptor antagonists of the release of noradrenaline.
Limberger N; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):240-6. PubMed ID: 6145100
[TBL] [Abstract][Full Text] [Related]
20. Selective blockade of brain alpha 2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine.
Andén NE; Pauksens K; Svensson K
J Neural Transm; 1982; 55(2):111-20. PubMed ID: 6294237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
